Host Cell Factors Open Door to Potential Novel Therapies for COVID-19

A new study advocates for drug development targeting host-cell factors, such as PCIF1 and TMPRSS2, to treat COVID-19.

Related Keywords

Riverside ,California ,United States ,San Diego ,University Of California San Diego ,Tariq Rana ,Institute Of Genomic Medicine ,Uc San Diego Health ,Moores Cancer Center ,Uc San Diego School Of Medicine ,California San Diego ,Distinguished Professor ,Diego School ,Genomic Medicine ,